Escalier Biosciences is developing both topical and oral RORγt inverse agonists for the treatment of a broad spectrum of psoriasis patients – from the underserved mild-to-moderate patients that would benefit from a safe and effective topical RORγt therapeutic to the more moderate-to-severe patients that would benefit from a safe and effective oral RORγt drug in lieu of injectable biologic therapies targeting IL-17 and IL-23.

Biotechnology

Education

Escalier Biosciences

Raju Mohan

Edward Van Wezel

Chris Krueger

John Nuss

The leadership team at Escalier Biosciences has a long history of experience in the field of chemistry and research. The team is made up of executives from Ventyx Biosciences, OPPILAN PHARMA LIMITED, and Escalier Biopharm B.V., as well as the CEO of Ventyx Biosciences. The team also has a wide range of educational experience, with degrees in chemistry from the University of Wisconsin-Madison, the University of Illinois Urbana-Champaign, and the Indian Institute of Technology, Bombay.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Escalier Biosciences

Board of Directors

CEO and Executive Team